U.S. Electrical Stock News

Stock Yards Bancorp, Inc. recently reported third quarter 2025 results, posting increases in both net interest income and net income compared to the previous year, and participated in key industry conferences in November. The company’s consistent earnings momentum, paired with active engagement at financial services forums, highlights its ongoing focus on operational performance within the sector. We'll examine how robust growth in quarterly net interest income shapes the company's current...

Murphy USA recently announced several major corporate actions, including weaker third-quarter results, a 19% increase in its quarterly dividend, a new US$2 billion share buyback program, and leadership changes with Mindy K. West set to become CEO and President in January 2026. This cluster of updates highlights both operational challenges, shown in declining revenue and profit, and the company’s emphasis on returning value to shareholders through increased dividends and expanded repurchases...

Immunocore Holdings (NasdaqGS:IMCR) attracted attention after unveiling new Phase 1 clinical results for its IMC-I109V candidate in hepatitis B, showing encouraging signals for both safety and immune response. These findings could pave the way for the next stage of clinical development. See our latest analysis for Immunocore Holdings. Immunocore’s latest news and conference appearances have fueled momentum, with the 1-day share price return up 4.5% and a 17.4% gain year-to-date. However,...

BioMarin Pharmaceutical announced that the FDA has accepted for Priority Review its supplemental Biologics License Application to expand PALYNZIQ® treatment for adolescents with phenylketonuria (PKU), setting a target action date of February 28, 2026. This regulatory milestone could increase PALYNZIQ’s eligible patient base and signals ongoing progress in BioMarin’s rare disease pipeline. We’ll look at how expanded adolescent access to PALYNZIQ may influence BioMarin’s future revenue growth...

NCR Atleos Corporation recently announced its third quarter 2025 earnings, reporting revenue of US$1.12 billion and net income of US$26 million, both higher than the previous year, while reaffirming its full-year 2025 revenue guidance. This improved financial performance coincides with ongoing innovation in digital banking, highlighted by the company’s collaboration with Kuwait Finance House to introduce AI-powered service avatars in branches. Next, we’ll explore how NCR Atleos’ stronger...

United Community Banks (UCB) just published its latest quarterly report, revealing year-over-year increases in revenue, net income, and earnings per share. The company’s acquisition of ANB also expands its footprint in Florida and aligns with broader growth plans. See our latest analysis for United Community Banks. UCB’s latest rally has sparked renewed optimism, yet the stock’s 1-year total shareholder return of -4.3% reflects lingering caution from the market, particularly after the...

IDEAYA Biosciences (IDYA) just announced strong third quarter earnings, swinging from a net loss last year to a net income of $119 million. The company also reported revenue of $208 million for the period. Investors are watching closely, as this marks a major financial turnaround for the company. See our latest analysis for IDEAYA Biosciences. IDEAYA Biosciences’ standout quarterly earnings have captured investor attention, but recent market momentum tells its own story. After a 30.95% 90-day...

Arcosa, Inc. recently reported third-quarter and nine-month 2025 earnings, announcing third-quarter sales of US$797.8 million and net income of US$73 million, both significantly higher than the prior year, and updated its full-year guidance with revenues expected between US$2.86 billion and US$2.91 billion. Amid robust performance, Arcosa’s revised guidance signals greater confidence in sustaining higher profitability following standout year-to-date results. We'll explore how Arcosa’s...

In early November 2025, uniQure announced that the U.S. Food and Drug Administration no longer supports using Phase I/II data with external controls as the primary evidence for a Biologics License Application for AMT-130, its investigational gene therapy for Huntington's disease. This sudden regulatory shift created uncertainty regarding the product’s approval pathway, despite recent promising clinical data and prior breakthrough designations for AMT-130. We'll explore how increased...

Yum! Brands has begun a formal review of strategic alternatives for its Pizza Hut business following ongoing underperformance in the U.S. This move could reshape the company’s portfolio and has important implications for investors. See our latest analysis for Yum! Brands. This decision to review options for Pizza Hut comes following several notable developments, including a third-quarter earnings lift and a new EV charging partnership for multiple U.S. locations. Yum! Brands has delivered a...

Bristol-Myers Squibb (BMY) shares have seen some movement recently, with the stock notching a modest gain over the past month. Investors are sizing up current valuation following a stretch of mixed performance this year. See our latest analysis for Bristol-Myers Squibb. Bristol-Myers Squibb’s recent momentum stands out with a 1-month share price return of 7.5 percent after a tough start to the year. Despite this uptick, the longer-term trend is still challenging, with the 1-year total...

Elanco Animal Health recently reported its third quarter 2025 results, showing higher sales of US$1.14 billion compared to US$1.03 billion a year ago, but posted a net loss of US$34 million versus net income of US$364 million last year and issued lowered full-year earnings guidance, expecting a net loss of US$41 million to US$56 million for 2025. This combination of improved sales and reduced earnings outlook suggests operational challenges are impacting profitability, even as the company...

NetScout Systems reported second-quarter revenue of US$219.02 million and net income of US$25.83 million, exceeding analyst expectations, and raised its full-year fiscal 2026 revenue and earnings guidance on November 6, 2025. Strong operational performance, key customer deal wins, significant share repurchases, and improved earnings outlook underscored accelerated momentum in both cybersecurity and service assurance segments. We'll assess how NetScout's upgraded earnings forecast and robust...

Aurinia Pharmaceuticals (AUPH) just delivered a strong show for investors with better-than-expected third quarter results and an updated outlook for 2025. The company raised both its revenue and net product sales guidance, which suggests growing confidence in its business trajectory. See our latest analysis for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals’ strong financial report and higher guidance have clearly energized the stock, with a 13% seven-day share price return and an...

Shares of e.l.f. Beauty (NYSE:ELF) slid after the company posted its latest earnings. The report revealed strong revenue growth, but a marked drop in profits driven by higher tariff burdens and increased marketing expenses. See our latest analysis for e.l.f. Beauty. Over the past year, momentum has dramatically shifted for e.l.f. Beauty. After a remarkable multi-year run, sentiment soured sharply as the stock plunged on disappointing profit guidance and ongoing tariff pressures. This has put...

Restaurant Brands International recently announced a joint venture with asset manager CPE to expand Burger King’s footprint in China from about 1,250 to more than 4,000 restaurants by 2035, supported by a US$350 million capital infusion. This collaboration with CPE, recognized for scaling consumer brands in China, marks a major commitment to international growth and market innovation for Burger King. We’ll now examine how Burger King’s planned expansion in China could reshape Restaurant...

McKesson Corporation recently reported strong second-quarter earnings, with sales rising to US$103.15 billion and net income jumping to US$1.11 billion compared to the prior year period, alongside a regular dividend affirmation and ongoing share repurchases. This surge in profitability highlights robust demand and operational execution, as McKesson continues to expand its specialty pharmaceuticals segment and enhance efficiency through technology investments. We'll look at how McKesson's...

Jack Henry & Associates (JKHY) just delivered first quarter results showing higher revenue and net income, and also raised its outlook for fiscal 2026. The company signed QCR Holdings to a multi-bank technology partnership, which adds another positive signal for future growth and competitive positioning. See our latest analysis for Jack Henry & Associates. Jack Henry & Associates has enjoyed a strong run after its first-quarter earnings beat and freshly raised guidance, with the share price...

Tractor Supply (TSCO) just rolled out an expanded selection of Field & Stream products to stores and online, building on customers’ enthusiasm for the initial offerings earlier this year. This expanded launch is part of a strategic, multi-year partnership with Field & Stream and includes more outdoor, hunting, and pet merchandise for shoppers to explore. See our latest analysis for Tractor Supply. Tractor Supply’s exclusive Field & Stream expansion comes on the heels of a quarterly dividend...

Caesars Entertainment (CZR) just released its third quarter results, with revenue roughly unchanged from last year and a wider net loss than before. The company also completed a sizable share buyback, repurchasing about 4.5% of its stock for $250 million. See our latest analysis for Caesars Entertainment. Despite the large buyback and steady revenue, Caesars Entertainment’s stock has faced heavy pressure this year, with a 1-year total shareholder return of -50.2%. Short-term momentum remains...

SFL Corporation reported its third-quarter 2025 earnings on November 11, 2025, following analyst projections of a slight loss per share and meaningful revenue decline amid recent estimate downgrades. Investor attention heightened due to concerns about SFL’s high debt, low liquidity, and the company’s valuation metrics suggesting possible undervaluation. With analysts recently downgrading SFL’s earnings and revenue outlook, we’ll examine the impact these financial headwinds may have on its...

Planet Labs PBC recently announced the renewal of an 8-figure contract with a longstanding international defense and intelligence customer for high-resolution satellite imagery, granting access to its Pelican and SkySat assured tasking services. This renewal further highlights Planet Labs PBC's strengthening position within the government space intelligence sector, following recent collaborations with several major governmental organizations. We’ll explore how this significant contract...

International Seaways (INSW) caught investors’ attention this week after reporting third quarter results and unveiling a combined dividend as well as an extension of its share repurchase program. These steps are shaping sentiment around the stock. See our latest analysis for International Seaways. After a steady string of shareholder-friendly moves and fleet updates, International Seaways’ stock has surged with a 1-month share price return of 23.3% and year-to-date climb of nearly 48%...

Zebra Technologies (ZBRA) has just released its third quarter results and outlined expectations for the upcoming quarter. Investors are paying close attention as the company anticipates sales growth, fueled in part by acquisitions and currency tailwinds. See our latest analysis for Zebra Technologies. Despite issuing upbeat guidance and completing a share repurchase program, Zebra Technologies’ share price has continued to face headwinds. The stock finished at $260.63 and delivered a one-year...